Andreas Kjær

Andreas Kjær

Professor


  1. Published

    Synthesis and characterization of 18F-labeled active site inhibited factor VII (ASIS)

    Erlandsson, M., Nielsen, Carsten Haagen, Jeppesen, T. E., Kristensen, J. B., Petersen, L. C., Madsen, J. & Kjær, Andreas, May 2015, In: Journal of Labelled Compounds and Radiopharmaceuticals. 58, 5, p. 196-201 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Synthesis and in vivo evaluation of [11C]tucatinib for HER2-targeted PET imaging

    Müller, Marius, Shalgunov, Vladimir, Hvass, Lars, Jørgensen, Jesper Tranekjær, Kramer, V., Staudt, Markus, Battisti, Umberto Maria, Kjær, Andreas & Herth, Matthias Manfred, 2023, In: Bioorganic and Medicinal Chemistry Letters. 80, 5 p., 129088.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Synthesis and radiolabeling of a polar [125 I]I-1,2,4,5-tetrazine

    Bidesi, N., Shalgunov, Vladimir, Battisti, Umberto Maria, Hvass, Lars, Jørgensen, Jesper Tranekjær, Poulie, C. B. M., Jensen, A. I., Kjær, Andreas & Herth, Matthias Manfred, 2023, In: Journal of Labelled Compounds and Radiopharmaceuticals. 66, 1, p. 22-30

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation

    Toner, Y. C., Ghotbi, A. A., Naidu, S., Sakurai, K., van Leent, M. M. T., Jordan, S., Ordikhani, F., Amadori, L., Sofias, A. M., Fisher, E. L., Maier, A., Sullivan, N., Munitz, J., Senders, M. L., Mason, C., Reiner, T., Soultanidis, G., Tarkin, J. M., Rudd, J. H. F., Giannarelli, C. & 6 others, Ochando, J., Pérez-Medina, C., Kjær, Andreas, Mulder, W. J. M., Fayad, Z. A. & Calcagno, C., 2022, In: Scientific Reports. 12, 1, 15 p., 6185.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Takotsubo cardiomyopathy is an acute cardiac syndrome induced by stress

    Fuchs, A. M., Bang, L. E., Holmvang, Lene, Hasbak, P., Kjær, Andreas & Christensen, T. E., 13 Jun 2016, In: Ugeskrift for Laeger. 178, 24

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Takotsubo-cardiomyopathy: a case of extremely fast recovery described by multimodality cardiac imaging

    Christensen, T. E., Ahtarovski, K. A., Andersson, H., Vejlstrup, N., Ihlemann, N., Kjær, Andreas, Holmvang, L., Bang, L., Grande, P. & Hasbak, P., 2012, In: Journal of Nuclear Cardiology. 19, 6, p. 1240-2 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Targeted imaging of uPAR expression in vivo with cyclic AE105 variants

    Leth, Julie Maja, Newcombe, Estella Anne, Grønnemose, A. L., Jørgensen, Jesper Tranekjær, Qvist, K., Clausen, Anne Skovsbo, Knudsen, Line Bruhn Schneider, Kjær, Andreas, Kragelund, Birthe Brandt, Jørgensen, Thomas Jørgen Dyreborg & Ploug, Michael, 2023, In: Scientific Reports. 13, 17 p., 17248.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180

    Engelholm, Lars Henning, Carlsen Melander, E. M., Hald, A., Persson, M., Madsen, D. H., Jürgensen, Henrik Jessen, Johansson, K., Nielsen, C., Nørregaard, Kirstine Sandal, Ingvarsen, S. Z., Kjær, Andreas, Trovik, C. S., Lærum, O. D., Bugge, T. H., Eide, J. & Behrendt, Niels, Jan 2016, In: Journal of Pathology. 238, 1, p. 120-33 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas

    Olsen, I. H., Federspiel, B., Kjær, Andreas, Hansen, C. P., Knigge, Ulrich & Langer, Seppo W., 2011, p. 38-38. 1 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  10. Published

    Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas

    Olsen, I. M. H., Sørensen, Jens Benn, Federspiel, B., Kjær, Andreas, Hansen, C. P., Knigge, Ulrich & Langer, S. W., 2012, In: Scientific World Journal. 2012, p. 170496 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13402